Helical raises $10M to bridge the gap between foundation models and drug discovery decisions

Helical raises $10M to bridge the gap between foundation models and drug discovery decisions

Pharma artificial intelligence startup Helical Ltd. announced today that it has raised $10 million in new funding to expand its virtual AI lab platform, which turns biological foundation models into reproducible in-silico drug discovery workflows. Founded in 2024, Helical was built around a specific gap its founders identified as biological foundation models have gained traction […] The post Helical raises $10M to bridge the gap between foundation models and drug discovery decisions appear...

Original Source

Read the full article at Siliconangle →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.